Detalhe da pesquisa
1.
Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer.
Ann Surg
; 271(4): 740-747, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30312198
2.
Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer.
HPB (Oxford)
; 22(12): 1745-1752, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32354656
3.
A Phase II Clinical Trial of Molecular Profiled Neoadjuvant Therapy for Localized Pancreatic Ductal Adenocarcinoma.
Ann Surg
; 268(4): 610-619, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30080723
4.
Venous thromboembolism prophylaxis during neoadjuvant therapy for resectable and borderline resectable pancreatic cancer-Is it indicated?
J Surg Oncol
; 114(5): 581-586, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27760280
5.
Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer.
HPB (Oxford)
; 17(10): 942-52, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26255895
6.
Diagnostic laparoscopy should be performed before definitive resection for pancreatic cancer: a financial argument.
HPB (Oxford)
; 17(2): 131-9, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25123702
7.
Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm?
Oncologist
; 19(3): 266-74, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24569947
8.
Staging chest computed tomography and positron emission tomography in patients with pancreatic adenocarcinoma: utility or futility?
HPB (Oxford)
; 16(1): 70-4, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23496023
9.
Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancer.
Invest New Drugs
; 30(2): 772-8, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21120580
10.
Neoadjuvant therapy for localized pancreatic cancer: support is growing?
Ann Surg
; 261(1): 18-20, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25599323
11.
Value of Pretreatment 18F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy.
Front Oncol
; 10: 500, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32363161
12.
Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer.
Surgery
; 168(3): 440-447, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32641278
13.
Role of Molecular Profiling of Pancreatic Cancer After Neoadjuvant Therapy: Does it Change Practice?
J Gastrointest Surg
; 24(2): 235-242, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31745905
14.
Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic Cancer.
Front Oncol
; 10: 460, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32351886
15.
Distal splenorenal and mesocaval shunting at the time of pancreatectomy.
Surgery
; 165(2): 298-306, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30471779
16.
Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery.
Surgery
; 166(3): 277-285, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31272811
17.
A randomized phase II trial of nab-paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer.
Cancer Med
; 8(11): 5148-5157, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31347292
18.
A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia.
J Support Oncol
; 6(1): 18-25, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18257397
19.
Locally advanced pancreas cancer: Staging and goals of therapy.
Surgery
; 163(5): 1053-1062, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29331400
20.
HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma.
J Clin Oncol
; 36(4): 359-366, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29232172